Virtual 12-Week Tai Chi Program to Improve Balance in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy

What this Trial Is About

Researchers are evaluating a 12-week virtual Tai Chi training program designed to improve balance and small nerve fiber function among cancer survivors who have chemotherapy-induced peripheral neuropathy CIPN. This pilot trial aims to determine if the Tai Chi program is feasible and acceptable for these individuals, who often experience balance difficulties related to their condition. Participants are randomly assigned to one of two groups the Tai Chi group or a waitlist control group. Those in the Tai Chi group attend virtual Tai Chi sessions twice weekly for 60 minutes and also perform independent Tai Chi exercises three days a week. The control group receives standard CIPN care and is offered Tai Chi training after completing the 12-week follow-up. The study includes baseline and 12-week follow-up visits. Throughout the 12 weeks, participants undergo screening, questionnaires, and sensory and functional testing to assess balance, strength, gait, mobility, pain, and neurotoxicity symptoms. Researchers track enrollment, session completion, and participant acceptability. Safety and functional outcomes are measured at baseline and after 12 weeks. The total duration of participation is approximately 12 weeks.

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)